Granuliberin-SSa

General Information


DRACP ID  DRACP01008

Peptide Name   Granuliberin-SSa

Sequence  FIFLPIFRRPVS

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Glandirana susurra

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma 50.5% Killing=32µg/ml MTT assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  COS-7: 88.5% Killing=32µg/ml; CPAE: 99.2% Killing=32µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01008

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C75H114N18O14

Absent amino acids  ACDEGHKMNQTWY

Common amino acids  F

Mass  168821

Pl  12.5

Basic residues  2

Acidic residues  0

Hydrophobic residues  7

Net charge  2

Boman Index  -550

Hydrophobicity  103.33

Aliphatic Index  121.67

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32751229

Title  Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens

Doi 10.3390/antibiotics9080457

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.